Emma Heming Willis Fights Back Tears While Encouraging Care Partners

Emma Heming Willis is doing her best amid her husband, Bruce Willis's dementia. The media personality recently exposed her vulnerable state to inspire others in the same shoes.

The "Die Hard" star's wife has been vocal about her struggles, frequently raising awareness of the do's and don'ts of caring for people with frontotemporal dementia. While she continues to support the Hollywood veteran alongside their two kids, the brunette tries to remain healthy.

In her latest wellness update, the runway alum implored her followers, particularly care partners, to share images of what they considered beautiful. Following numerous positive responses, the former model got emotional, reflecting on the importance of living in the moment and overcoming the pressure of her responsibilities.

Taking to her Instagram, "The Victoria's Secret Fashion Show" participant got candid about her life behind closed doors as her husband's primary caretaker. She started the lengthy conversation by thanking care partners for sharing various beautiful pictures following her prompt.

After taking a hike the mother of two filmed herself inside a car. The 45-year-old revealed she was "happy" with the snaps she received, noting the reason behind the exercise was to help herself and her fellow care partners.

"So why am I asking you to do that? I am asking care partners to send me photos because I just think it's so important for us to sort of break up our thinking," Emma explained. "Which can feel for me very much like doom and gloom."

Although she left Bruce behind to embrace nature for her hike, the Malta native clarified that her actions were not selfish. According to the entertainer, the happy moments she shared on social media were far from what she genuinely felt on the inside.

"So I know it looks like I'm out living my best life. I have to make a conscious effort every single day to live the best life that I can," the former model confessed, her voice cracking from the weight of unshed tears filling her eyes.

Fighting back the pain, the media personality declared: "I do that for myself. I do that for our two children and Bruce, who would not want me to live any other way. So I don't want it to be misconstrued like I'm good. Cuz I'm not. I'm not good."

Despite her broken heart, the "Death Becomes Her" actor's wife stated she could not be overwhelmed for her loved one's sake. The most efficient way the brunette could effectively care for her family was by being in the best shape possible.

"I have to put my best foot forward for the sake of myself and my family. Because again, when we are not looking after ourselves, we cannot look after anyone that we love," Emma claimed, advising viewers to prioritize their well-being.

Reaffirming that taking time for her health was a challenging task; the 45-year-old stated she was "doing the best" she could and used the picture prompt to help care partners do the same.

"I know that your day is stressful. I know that your day is hard. But I just want you just to break it up for a minute. Just for a second and just look for something beautiful," Emma concluded her post, flashing viewers an endearing smile.

Emma's recent post is not the first time the former model had opened up about her struggles. In May, the mother of two updated her Instagram followers about a possible frontotemporal dementia drug that failed its clinical trials.

The 45-year-old shared a video of herself at home reading from an obscured screen and looking disappointed by the contents. The media personality explained she had stumbled across an article detailing a "potential treatment drug" for FTD.

Unfortunately, the medicine did not pass its clinical trials. Lamenting about the outcome, Emma noted it was "truly a blow because there are no drugs that can treat FTD, only drugs that can treat symptoms."

In a second video, the "Perfect Stranger" actress noted she did not wish to end her message with negativity. According to the mother of two, the article continued with hope for future improvements.

Although the drug's clinical trials did not uncover medicinal benefits to those with FTD or ALS, the test results would allegedly "chart a promising path toward future treatments."